Embedding patient journeys into clinical and commercial planning, for more focused decisions and improved patient outcomes.
On April 21st, 2021 Cello Health hosted its first ‘Pharma Progress’ – a brand new virtual event aiming to explore some of healthcare’s most imperative challenges and how these are being addressed. Our first topic focussed on the patient and the patient journey. The speaker and panellist discussions were both dynamic and insightful, and we have captured the key themes and discussion points in a summary paper available for you to download now.
The US Forecaster’s Check List for Japan: A World of Difference
Expanding the valuation of a biopharmaceutical asset to Japan requires a new mindset in nearly every input of forecasting, with many pitfalls. Doug Willson, Senior Vice President, Cello Health Advantage and Tiffany Ahlers, Chief Commercial Officer, Mycovia Pharmaceuticals Inc., share a checklist to improve the rigor and validity of product forecasts for Japan.
Using organic and unfiltered social media data, Cello Health is proud to share with you the first in a series of reports aimed at centralizing and amplifying the authentic patient experience.
Happy MedComms Day 2021 from Cello Health’s Global Communications Team
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us